Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Clinical trial NCT02979873 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02979873
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-19
- Primary completion
- 2025-09-04
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.